Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Fluzone Intradermal Quadrivalent in Adults
NCT01712984Phase 3Completed
- Sponsor
- Sanofi
- Start
- Oct 2012
- Primary completion
- Jun 2013
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines, Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of Fluzone Intradermal in influenza, sponsored by Sanofi. Started Oct 2012; status: completed.
02
Drugs
Fluzone Intradermal
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01712984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01712984.